PA8441701A1 - Sales dimesilato de los ligandos del neuropeptido y - Google Patents

Sales dimesilato de los ligandos del neuropeptido y

Info

Publication number
PA8441701A1
PA8441701A1 PA19978441701A PA8441701A PA8441701A1 PA 8441701 A1 PA8441701 A1 PA 8441701A1 PA 19978441701 A PA19978441701 A PA 19978441701A PA 8441701 A PA8441701 A PA 8441701A PA 8441701 A1 PA8441701 A1 PA 8441701A1
Authority
PA
Panama
Prior art keywords
dimesylate
salts
neuropeptide ligands
neuropeptide
ligands
Prior art date
Application number
PA19978441701A
Other languages
English (en)
Spanish (es)
Inventor
Douglas Allen
Alireza Kord
Laurie Whipple
Lyle Robinson Brostrom
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8441701A1 publication Critical patent/PA8441701A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PA19978441701A 1996-11-26 1997-11-18 Sales dimesilato de los ligandos del neuropeptido y PA8441701A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
PA8441701A1 true PA8441701A1 (es) 2000-05-24

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978441701A PA8441701A1 (es) 1996-11-26 1997-11-18 Sales dimesilato de los ligandos del neuropeptido y

Country Status (23)

Country Link
US (1) US5914329A (cg-RX-API-DMAC7.html)
EP (1) EP0944611B1 (cg-RX-API-DMAC7.html)
JP (1) JP3120861B2 (cg-RX-API-DMAC7.html)
AP (1) AP9701148A0 (cg-RX-API-DMAC7.html)
AR (1) AR010304A1 (cg-RX-API-DMAC7.html)
AT (1) ATE257472T1 (cg-RX-API-DMAC7.html)
AU (1) AU4792497A (cg-RX-API-DMAC7.html)
BR (1) BR9713538A (cg-RX-API-DMAC7.html)
CA (1) CA2272927C (cg-RX-API-DMAC7.html)
DE (1) DE69727155T2 (cg-RX-API-DMAC7.html)
DK (1) DK0944611T3 (cg-RX-API-DMAC7.html)
ES (1) ES2213207T3 (cg-RX-API-DMAC7.html)
GT (1) GT199700123A (cg-RX-API-DMAC7.html)
HN (1) HN1997000154A (cg-RX-API-DMAC7.html)
HR (1) HRP970640A2 (cg-RX-API-DMAC7.html)
ID (1) ID18964A (cg-RX-API-DMAC7.html)
MA (1) MA26450A1 (cg-RX-API-DMAC7.html)
PA (1) PA8441701A1 (cg-RX-API-DMAC7.html)
PE (1) PE17099A1 (cg-RX-API-DMAC7.html)
PT (1) PT944611E (cg-RX-API-DMAC7.html)
TN (1) TNSN97191A1 (cg-RX-API-DMAC7.html)
WO (1) WO1998023603A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA9710587B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
EP2002827A2 (en) 2001-12-05 2008-12-17 The Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
WO2003057886A2 (en) 2002-01-09 2003-07-17 Arexis Ab Detection of mutations
KR100716389B1 (ko) * 2004-11-23 2007-05-11 동화약품공업주식회사 N-히드록시-4-{5-[4-(5-이소프로필-2-메틸-1,3-티아졸-4-일)페녹시]펜톡시}벤즈아미딘 2메탄술폰산염
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
DE69727155D1 (de) 2004-02-12
DK0944611T3 (da) 2004-04-13
US5914329A (en) 1999-06-22
DE69727155T2 (de) 2004-07-08
HRP970640A2 (en) 1998-10-31
AP9701148A0 (en) 1998-01-31
EP0944611A1 (en) 1999-09-29
CA2272927A1 (en) 1998-06-04
JP3120861B2 (ja) 2000-12-25
ID18964A (id) 1998-05-28
WO1998023603A1 (en) 1998-06-04
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
GT199700123A (es) 1999-05-19
ZA9710587B (en) 1999-05-25
ES2213207T3 (es) 2004-08-16
PT944611E (pt) 2004-04-30
MA26450A1 (fr) 2004-12-20
HN1997000154A (es) 1999-02-09
TNSN97191A1 (fr) 2005-03-15
AR010304A1 (es) 2000-06-07
JP2000505110A (ja) 2000-04-25
BR9713538A (cg-RX-API-DMAC7.html) 2000-03-21
EP0944611B1 (en) 2004-01-07
ATE257472T1 (de) 2004-01-15
AU4792497A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
ES2182906T3 (es) Grapa quirurgica helicoidal.
ATE234092T1 (de) 2-alkylpyrrolidine
ATE422329T1 (de) Verarbeitung von elektrokardiogrammsignälen mit überlappenden komplexen
SE0203752D0 (sv) New compounds
FI930772A0 (fi) Hydroxiureaderivat som saenker glugosnivao i blodet
DK0767669T3 (da) Nyt farmaceutisk præparat til smertebehandling
ATE200895T1 (de) Betain-geminitenside auf der basis von aminen
NO904595D0 (no) Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoid.
DE69830297D1 (de) Arylpiperazine die Wirkung auf den Serotonin 1a Rezeptor haben
DE69610825D1 (de) Zahnbürste
EA199900912A1 (ru) Фармацевтические средства
DE69524623D1 (de) Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen
ATE230250T1 (de) Rettungsvorrichtung
SE9401174D0 (sv) New combination
ECSP972321A (es) Sales dimesilato de los ligandos del neuropeptido y antecedentes de la invencion
ES2157479T3 (es) Crisol de escoria para tratamiento de escoria.
EA200200798A1 (ru) Кальцилитические соединения
ES269428Y (es) Disposicion de napa.
ATE322898T1 (de) Inhibitoren von mycobakterien
AP9701148A0 (en) Dimesylate salts of neuropeptide Y ligands.
ATE373475T1 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen
MX9300268A (es) Nuevas 4-cinolinil-y 4-naftiridinil-dihidropiridinas, procedimiento para su obtencion y medicamentos que las contienen.
SE8402081D0 (sv) Substituerad difenylazometin
ITRM950066A0 (it) Procedimento per la produzione di poliammide con aumentata rigidita'.
LV11649A (lv) Panemiens preces razotaja identificesanai